The stock of Agenus Inc (AGEN) has gone up by 22.26% for the week, with a -21.70% drop in the past month and a -43.73% drop in the past quarter. The volatility ratio for the week is 13.80%, and the volatility levels for the past 30 days are 10.54% for AGEN. The simple moving average for the past 20 days is 8.41% for AGEN’s stock, with a -63.21% simple moving average for the past 200 days.
Is It Worth Investing in Agenus Inc (NASDAQ: AGEN) Right Now?
The 36-month beta value for AGEN is at 1.44. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for AGEN is 24.66M, and currently, shorts hold a 14.72% of that float. The average trading volume for AGEN on April 08, 2025 was 428.84K shares.
AGEN) stock’s latest price update
Agenus Inc (NASDAQ: AGEN)’s stock price has gone rise by 17.95 in comparison to its previous close of 1.56, however, the company has experienced a 22.26% increase in its stock price over the last five trading days. businesswire.com reported 2025-03-25 that LEXINGTON, Mass.–(BUSINESS WIRE)–Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced two upcoming presentations at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 25–30, 2025 in Chicago, Illinois. The presentations continue to build momentum for Agenus’ neoadjuvant immunotherapy program with botensilimab and balstilimab (BOT/BAL), including an oral presentation of the initial results from the NEOASIS trial in solid tumors and a poste.
Analysts’ Opinion of AGEN
Many brokerage firms have already submitted their reports for AGEN stocks, with Robert W. Baird repeating the rating for AGEN by listing it as a “Neutral.” The predicted price for AGEN in the upcoming period, according to Robert W. Baird is $8 based on the research report published on July 19, 2024 of the previous year 2024.
H.C. Wainwright gave a rating of “Neutral” to AGEN, setting the target price at $9 in the report published on July 18th of the previous year.
AGEN Trading at -29.42% from the 50-Day Moving Average
After a stumble in the market that brought AGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -90.65% of loss for the given period.
Volatility was left at 10.54%, however, over the last 30 days, the volatility rate increased by 13.80%, as shares sank -14.42% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -48.46% lower at present.
During the last 5 trading sessions, AGEN rose by +22.26%, which changed the moving average for the period of 200-days by -85.84% in comparison to the 20-day moving average, which settled at $1.6973. In addition, Agenus Inc saw -32.85% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for AGEN
Current profitability levels for the company are sitting at:
- -1.16 for the present operating margin
- 0.24 for the gross margin
The net margin for Agenus Inc stands at -2.2. The total capital return value is set at -24.74.
Based on Agenus Inc (AGEN), the company’s capital structure generated -0.41 points at debt to capital in total, while cash flow to debt ratio is standing at -1.67. The debt to equity ratio resting at -0.29. The interest coverage ratio of the stock is -1.02.
Currently, EBITDA for the company is -101.3 million with net debt to EBITDA at -0.54. When we switch over and look at the enterprise to sales, we see a ratio of 0.98. The receivables turnover for the company is 254.21for trailing twelve months and the total asset turnover is 0.46. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.21.
Conclusion
In conclusion, Agenus Inc (AGEN) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
